HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Regulator ID’s Underpreserved Cosmetics As Adverse-Event Contributor

This article was originally published in The Rose Sheet

Executive Summary

Australia’s Competition and Consumer Commission says that 30% of all consumer product injury reports it received in the past year were associated with cosmetics, which it partially attributes to inadequate product preservation. In addition to promoting good manufacturing practices, the ACCC will be surveying cosmetic product labeling on a continuing basis.

You may also be interested in...



FDA Updates Its Microbiological Safety Webpage Amid Recall Flurry

Gilchrist & Soames’ recall of bath and body products due to microbial contamination marks a five-month trend in FDA’s enforcement reports. On its Microbiological Safety webpage, updated Feb. 12, FDA refers to a public meeting it held on the issue in 2011, where industry representatives warned that a shrinking preservative palette could put consumers at risk.

In Brief

Rockline Industries recalls baby and personal wipes due to mold contamination; Symrise strengthens its position in West Africa with new Nigerian subsidiary; P&G’s operations are suspended in Argentina due to alleged tax evasion. More news in brief.

Industry News Roundup

Prestige international sales jump; P&G settles Whitestrips infringement case; BlueOcean targets Indian omega-3 market; ViaDerma shop its dual carrier transdermal delivery; unapproved drugs make prostate, rosacea claims; and more industry news.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel